There is a lack of specific drug for a comprehensive medical treatment for ACLF. Moreover, the novel treatment options are in premature stage. There is no cure for ACLF on the background of high shortterm mortality, making LT desirable in this group. Balance between the dynamics of ACLF and the allocation of the organs has not been found in the actual clinical practice. Timely evaluation and admission to the LT waiting list and prioritization of patients with ACLF within the narrow window of opportunity improves outcome and reduces futility. Careful selection of patients and timely LT saves precious life. Hence, ACLF patients should receive priority on LT wait list.
Dr. Sanjiv Saigal is an Principal Director & Head Liver Transplant and Biliary Sciences, Gastroenterology, Hepatology & Endoscopy. He has completed CCST-(Gastroenterology), UK (2005) MRCP from Royal College of Physicians, Edinburg, UK (1999) DM-(Gastroenterology) from GB Pant, Delhi (1998) DNB (Gastroenterology) from NBE, Delhi (1996) MD- (Medicine) from PGI Chandigarh (1994) MBBS-(Gold Medalist) from Calcutta University (1989).
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details